About Meril Life Sciences Private Limited
Data last updated:
Meril Life Sciences Private Limited is a private limited company based in Vapi, Gujarat, India, a subsidiary of Micro Life Sciences Private Limited. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 19 June 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24239GJ2007PTC051137. Its GSTIN is 24AAFCM1444G1ZT (Gujarat). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹100 Cr and a paid-up capital of ₹99.36 Cr. It is led by directors including Nanubhai Premjibhai Bambharolia (Whole-Time Director) and Rajnikant Gandalal Vyas (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 July 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bilakhia House Survey No. 135/139 Muktanand Marg Chala, Vapi, Gujarat, India – 396191.
As per the financials filed for FY 2025, the company reported a revenue of ₹1,729.52 Cr, a growth of 44% compared to the previous year. For the same year it recorded a net profit of ₹425.45 Cr (net margin 24.6%) and EBITDA of ₹646.12 Cr (EBITDA margin 37.4%). Revenue has grown at a compounded annual rate (CAGR) of 52% over three years and 32% over five years.
The company has about 1,584 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 4 brands: Myval, Misso, Merilvet and Meril. As per MCA filings, the company has open charges of ₹788.45 Cr and satisfied charges of ₹228.76 Cr on record. Court records list 8 cases involving the company, including 2 filed by the company and 6 filed against it; 2 cases are pending. The company has 6 deals on record (4 funding rounds, 2 secondary share transfers), with disclosed funding of ₹113.05 Cr; the latest was in March 2023. Its 10 peer companies in the Healthcare industry (Medical and Laboratory Equipment) are compared by revenue, 5 larger and 5 smaller; the largest is Matrix Pharmacorp Private Limited with revenue of ₹4,422.21 Cr. The company has 5 MSME Form 1 returns on record between 2019 and 2024, listing 132 overdue payments to 25 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website merillife.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressBilakhia House Survey No. 135/139 Muktanand Marg Chala, Vapi, Gujarat, India – 396191
- IndustryHealthcare, Medical & Laboratory Equipment
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Meril Life Sciences Private Limited
The main business activity of Meril Life Sciences is manufacturing. In detail, this covers other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C13 | Other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Meril Life Sciences Private Limited FY 2025 filings available
Meril Life Sciences Private Limited reported revenue of ₹1,729.52 Cr (up 44% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Meril Life Sciences Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 32% over five years, including 44% growth in the latest year. EBITDA rose 107% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Meril Life Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | ₹1,729.52 Cr | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹646.12 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹425.45 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Meril Life Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 37.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 24.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Meril Life Sciences are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Meril Life Sciences Private Limited
Meril Life Sciences Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Medical and Laboratory Equipment). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Matrix Pharmacorp Private Limited | ₹4,422.21 Cr (FY 2025) | •••• | •••• | 16378466.0% | •••• | Sangareddy, Telangana, India |
| Carl Zeiss India (Bangalore) Private Limited | ₹2,410.04 Cr (FY 2025) | •••• | •••• | 17.0% | •••• | Bangalore, Karnataka, India |
| Integris Medtech Limited | ₹1,959.58 Cr (FY 2025) | •••• | •••• | 239.0% | •••• | New Delhi, Delhi, India |
| Ge Be Private Limited | ₹1,830.07 Cr (FY 2025) | •••• | •••• | 5.0% | •••• | Bangalore, Karnataka, India |
| Poly Medicure Limited Listed | ₹1,758.96 Cr (FY 2025) | •••• | •••• | 23.0% | •••• | New Delhi, Delhi, India |
| Meril Life Sciences Private Limited this company | ₹1,729.52 Cr (FY 2025) | •••• | •••• | 44.0% | •••• | Vapi, Gujarat, India |
| Becton Dickinson India Private Limited. | ₹1,621.05 Cr (FY 2025) | •••• | •••• | 19.0% | •••• | New Delhi, Delhi, India |
| Transasia Bio-Medicals Limited | ₹1,450.31 Cr (FY 2025) | •••• | •••• | -9.0% | •••• | Mumbai, Maharashtra, India |
| Meril Healthcare Private Limited | ₹1,411.5 Cr (FY 2025) | •••• | •••• | 20.0% | •••• | Vapi, Gujarat, India |
| Mindray Medical India Pvt. Ltd. | ₹1,216.99 Cr (FY 2025) | •••• | •••• | 16.0% | •••• | Mumbai, Maharashtra, India |
| Borosil Limited Listed | ₹1,134.78 Cr (FY 2025) | •••• | •••• | 18.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Meril Life Sciences by revenue in the Healthcare industry (Medical and Laboratory Equipment), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Meril Life Sciences Private Limited
Meril Life Sciences Private Limited is audited by DELOITTE HASKINS & SELLS LLP for the financial year 2025.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| DELOITTE HASKINS & SELLS LLP | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Meril Life Sciences Private Limited
Meril Life Sciences has 3 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nanubhai Premjibhai Bambharolia Also directs: Maxwell Eco-Green Private Limited, Milestone Holdings & Infrastructure Private Limited, Mitsu Private Limited and 2 more | Whole-Time Director | 19 Jun 2007 | 19 Years 3 Months | Current |
| Rajnikant Gandalal Vyas Also directs: Meril Diagnostics Private Limited, Meril Endo Surgery Private Limited, Mapel Infrastructure Private Limited and 2 more | Whole-Time Director | 20 Oct 2010 | 15 Years 11 Months | Current |
| Hemchandra Yadunandan Panjikar | Director | 11 Mar 2023 | 3 Years 7 Months | Current |
Ownership and Shareholding of Meril Life Sciences Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Meril Life Sciences Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Nov 2024 | Others | ₹144 Cr | Open |
| 13 Jun 2023 | Others | ₹146 Cr | Open |
| 28 Sep 2021 | Others | ₹110 Cr | Open |
| 25 Jun 2019 | Hdfc Bank Limited | ₹120 Cr | Open |
| 07 Jun 2019 | Others | ₹20 Cr | Open |
Total charge records: 15 View all charges
Deals & Funding of Meril Life Sciences Private Limited
Meril Life Sciences Private Limited has 6 deals on record (4 funding rounds, 2 secondary share transfers), with disclosed funding of ₹113.05 Cr; the latest was in March 2023.
Deals on record (4 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2023 | Secondary share transfer | Undisclosed | Buyer: Micro Life Sciences Private Limited Seller: M3 Investments |
| Mar 2011 | Funding round | ₹58.35 Cr | Investors: Micro Life Sciences Private Limited |
| Mar 2011 | Secondary share transfer | Undisclosed | Buyer: Micro Life Sciences Private Limited Seller: an individual |
| Oct 2008 | Funding round | ₹1 Cr | Investors: an individual |
Full deal history
All 6 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Meril Life Sciences Private Limited
Meril Life Sciences Private Limited has 8 court cases on record: 2 filed by Meril Life Sciences, 6 filed against it. 2 cases are pending and 6 are disposed. Status as checked between 21 Sep 2026 and 05 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 4 | 2 | 1 |
| Supreme Court | 2 | 2 | 0 |
| District courts | 2 | 2 | 1 |
Cases on record (5 of 8)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Gujarat | Special civil application | Filed by the company against Union of India | Pending |
| District court, Valsad, Gujarat | Commercial matter | Filed against the company by Natec Medical Ltd | Pending |
| High Court of Gujarat | Appeal | Filed against the company by Natec Medical Ltd | Disposed |
| District court, Valsad, Gujarat | Court case (CMA DC) | Filed against the company by Natec Medical Ltd | Disposed |
| High Court of Gujarat | Special civil application | Filed by the company against Assistant Commissioner of Income Tax Vapi Circle Vapi | Disposed |
Full case history
All 8 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Meril Life Sciences Private Limited
Meril Life Sciences Private Limited has 5 MSME Form 1 returns on record between 2019 and 2024, listing 132 overdue payments to 25 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 25)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Databank Computer Services | •••• | •••• | •••• |
| Bombay Tools Supplying Agency | •••• | •••• | •••• |
| Prakash Teleservices Private Limited | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Life Line Surgichem (India) Private Limited | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 5 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Associated Brands with Meril Life Sciences Private Limited
Meril Life Sciences operates multiple associated brands including Myval, Misso, and Merilvet. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers a transcatheter aortic heart valve replacement system. | myval.com | |
| MISSO provides robotic assistance for accurate joint replacements using 3D scans. | misso.ai | |
| Medical device innovation in orthopedics, endo-surgery, and diagnostics. | merilvet.com | |
| Developer of medical devices for surgeries and diagnosis | merillife.com |
Employees and EPFO Compliance at Meril Life Sciences Private Limited
Meril Life Sciences Private Limited has a workforce of 1,584 employees as of Sep 25, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Group Structure of Meril Life Sciences Private Limited
Meril Life Sciences has 1 subsidiary company. This group structure data is as of FY 2022. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares Held |
|---|---|---|
| Meril Life Sciences India Private Limited | U33110GJ1999PTC060787 | Locked |
Showing major subsidiaries. Total: 1.
News related to Meril Life Sciences Private Limited
Recent Activity on Meril Life Sciences Private Limited
Meril Life Sciences Private Limited has 10 board changes on record since 2007: 3 appointments and 7 cessations. The latest: Hemchandra Yadunandan Panjikar ceased to be Additional Director on 08 Sep 2023.
30 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Meril Life Sciences Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Meril Life Sciences Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Meril Life Sciences Private Limited
Meril Life Sciences has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAFCM1444G1ZT | Gujarat | Active | 01 Jul 2017 |
| 27AAFCM1444G1ZN | Maharashtra | Active | 22 Aug 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Meril Life Sciences Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Meril Life Sciences Private Limited
Meril Life Sciences is an active private limited company based in Vapi, Gujarat, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 19 June 2007 (19+ years old) and is registered under CIN U24239GJ2007PTC051137.
Meril Life Sciences reported revenue of ₹1,729.52 Cr for FY 2025 (up 44% YoY).
Meril Life Sciences has 3 current directors:
- Nanubhai Premjibhai Bambharolia - Whole-Time Director
- Rajnikant Gandalal Vyas - Whole-Time Director
- Hemchandra Yadunandan Panjikar - Director
Meril Life Sciences reported a net profit of ₹425.45 Cr (net margin 24.6%) and EBITDA of ₹646.12 Cr (EBITDA margin 37.4%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Meril Life Sciences is 52% over three years and 32% over five years. In the latest year (FY 2025) revenue rose 44%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Meril Life Sciences is 24AAFCM1444G1ZT, registered in Gujarat. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 27AAFCM1444G1ZN (Maharashtra).
The CIN (Corporate Identification Number) of Meril Life Sciences is U24239GJ2007PTC051137. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Meril Life Sciences has 8 court cases on record: 2 filed by the company and 6 filed against it. 2 are pending. Most are in the high courts.
Meril Life Sciences was incorporated on 19 June 2007, making it 19+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Meril Life Sciences has 6 deals on record (4 funding rounds, 2 secondary share transfers), with disclosed funding of ₹113.05 Cr; the latest was in March 2023.
The peers of Meril Life Sciences by revenue are Matrix Pharmacorp Private Limited, Carl Zeiss India (Bangalore) Private Limited, Integris Medtech Limited, Ge Be Private Limited, Poly Medicure Limited and 5 more, all in the Healthcare industry (Medical and Laboratory Equipment).
Hemchandra Yadunandan Panjikar ceased to be Additional Director on 08 Sep 2023. Hemchandra Yadunandan Panjikar was appointed as Director on 11 Mar 2023. Dinesh Jain ceased to be Company Secretary on 07 Mar 2020. Meril Life Sciences has 10 board changes on record in total.